Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression

Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression

US Patent 8551774 · Granted Oct 8, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intrabodies for reducing FUT8 activity2025
Antibodies and antibody fragments against HNAV1.7 channel and their use in pain 2024
Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain ant2023
Antibody glycoconjugates and methods of production and use2023
Enhanced production of recombinant proteins by transient transfection of suspens2020
Humanized antibodies transmigrating the blood-brain barrier and uses thereof2020
Carbonic anhydrase IX-specific antibodies and uses thereof2019
Enhanced production of recombinant proteins by transient transfection of suspens2019
Process, vectors and engineered cell lines for enhanced large-scale transfection2016
Expression system with SAR element from IFNα22015
Process, vectors and engineered cell lines for enhanced large-scale transfection2014
CRE-inducible expression system2003